Is Geron A Buyout Target? The RPRX Deal Says No
We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...
Bond Dealers Lock Horns Over Inflation-Protected Bond Supply
A small coterie of Wall Street dealers say it’s time for the US Treasury to resume increasing the size of its 30-year ...